[
  {
    "ts": null,
    "headline": "NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing",
    "summary": "Lecanemab has secured approvals in 50 countries and is under review in 10 others.",
    "url": "https://finnhub.io/api/news?id=e8aaa91ee2db033bdb6ee7f41a9ec47d88c1cdda8c1cc337313844cab9ae648c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759229367,
      "headline": "NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing",
      "id": 136936360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Lecanemab has secured approvals in 50 countries and is under review in 10 others.",
      "url": "https://finnhub.io/api/news?id=e8aaa91ee2db033bdb6ee7f41a9ec47d88c1cdda8c1cc337313844cab9ae648c"
    }
  }
]